Scientists recently tested a new pill for pancreatic cancer and the results were better than expected. In the trial, patients who took the drug lived nearly twice as long compared to those who didn’t. Pancreatic cancer is one of the toughest cancers to treat, so this discovery could be a big step fo
Treating a fast-growing cancer like advanced endometrial cancer used to rely only on looking at tumor cells under a microscope. Now, doctors use genetic testing to guide treatment instead. The biggest shift has come from drugs that help the immune system fight cancer. For some patients, these treatm
A small biotech company is getting a big boost from artificial intelligence in its search for cancer treatments. Instead of relying only on lab tests and guesswork, the firm is using AI to speed up how it designs and picks new drug candidates. This approach isn’t just a small tweak—it’s reshaping ho
A new experimental drug from Novartis is making waves in the fight against prostate cancer. Early trial results show it shrinks tumors in patients, even those who stopped responding to the company's existing treatment, Pluvicto. The drug uses a different radioactive element called actinium-225, whic
Many people moving into long-term care centers already face a hidden problem: their muscles weaken faster than normal. Doctors call this sarcopenia, and it shows up in scans and tests long before people notice it. Yet most care guidelines focus on diseases like diabetes or heart issues, not on keepi
ALS is a rare but cruel disease that slowly shuts down the body while leaving the mind intact. Doctors have only approved three drugs for it since the mid-1990s, and none of them cure or stop the disease—they merely slow it down a little. Part of the problem is money. Running trials for ALS is extre
The study tested a special floss that has 2% chlorhexidine, a strong cleaning chemical. Researchers wanted to know if it helps adults with gum inflammation (gingivitis). They randomly divided people into two groups. One group used the chlorhexidine‑floss every day for a month. The other
A research team set out to see if breathing exercises before operations could lower lung problems after surgery. The study involved patients scheduled for heart, chest and belly surgeries in the UK’s National Health Service. They ran a randomised controlled trial, meaning some patients received t
Doctors often face tough choices when treating aggressive brain tumors. A recent trial looked at how well a drug called regorafenib works in newly diagnosed and recurring glioblastoma cases. Instead of traditional methods, researchers used a flexible approach where patient data influenced treatment
In Canada, researchers often submit applications to ethics boards before starting a study. These forms normally ask for basic details about the trial, but they rarely prompt investigators to think about who will benefit from the research or how patients will be involved in decisions. The study lo
